Benchmark upgraded Repligen rating to buy, while Jefferies Financial Group reaffirmed a hold rating on the company.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benchmark upgraded Repligen rating to buy, while Jefferies Financial Group reaffirmed a hold rating on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Repligen
bioTech Company
Nothing else this week.
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
-
Jefferies Financial Group
American financial services company
Related events
- Jefferies Financial Group reissued a hold rating on June 18, 2026.
- Jefferies Financial Group reissued a 'hold' rating on The Renewables Infrastructure Group, a company listed on the London Stock Exchange.
- Jefferies Financial Group reissued a buy rating for Dassault Aviation, while MarketBeat aggregated the stock data.
- Jefferies Financial Group reaffirmed a hold rating on Drilling Tools International.
- MarketBeat provided consensus ratings and target prices, while Jefferies Financial Group reaffirmed a hold rating on Target Healthcare REIT.